This two-day event is dedicated to advancing innovation in cancer immunotherapy and biomarker science. The agenda will cover the latest in antibody-drug conjugates (ADCs), bispecific antibodies, cellular therapies, immune checkpoint inhibitors, and novel combination strategies, along with insights into pre-clinical research, translational approaches, and the evolution of personalized immunotherapy.

A strong emphasis will be placed on biomarker discovery, immune monitoring, vaccine development, and the integration of multi-omic platforms. Through cutting-edge sessions and expert-led discussions, the summit will highlight how scientific breakthroughs are reshaping oncology and driving the development of more precise, effective cancer treatments.